Skip to main content

ULTRALIFE CORP

For the period ended Apr 1, 2025. Filed Apr 1, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Apr 1, 2025 · Filed Apr 1, 2025

Use the contents to explore the available documents and sections.

ULBI$15.66+0.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Adjusted EBITDA

Adjusted EBITDA

In evaluating our business, we consider and use adjusted EBITDA, a non-GAAP financial measure, as a supplemental measure of our operating performance in addition to U.S. Generally Accepted Accounting Principles (“GAAP”) financial measures. We define adjusted EBITDA as net income attributable to Ultralife Corporation before net interest expense, provision for income taxes, depreciation and amortization, and stock-based compensation expense, plus/minus expense/income that we do not consider reflective of our ongoing continuing operations. We reconcile adjusted EBITDA to net income attributable to Ultralife Corporation, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EBITDA as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EBITDA to net income attributable to Ultralife Corporation.

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EBITDA

(Dollars in Thousands)

(Unaudited)

Three-Month Period EndedYear Ended
December 31, 2024December 31, 2023December 31, 2024December 31, 2023
Net Income Attributable to Ultralife Corporation$194$2,873$6,312$7,197
Adjustments:
Interest Expense, Net8295661,9402,016
Income Tax Provision2622631,8921,951
Depreciation Expense8317403,1253,022
Amortization Expense3482261,032889
Stock-Based Compensation Expense208104698528
Cyber-Insurance Policy Deductible---100
Non-Recurring Acquisition Costs1,111-1,361-
Non-Cash Purchase Accounting Adjustment120-120-
Adjusted EBITDA$3,903$4,772$16,480$15,703
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.